Catyalyst Pharma (CPRX) Reports In-Line Q3 EPS
Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.